Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers
Authors:
Open Access
- 18 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 909388
Abstract
Lymphatic metastasis influences clinical treatment and prognosis of patients with non-small-cell lung cancer (NSCLC). There is an urgency to understand the molecular features and mechanisms of lymph node metastasis. We analyzed the molecular features on pairs of the primary tumor and lymphatic metastasis tissue samples from 15 NSCLC patients using targeted next-generation sequencing. The potential metastasis-related genes were screened from our cohort based on cancer cell fraction. After filtering with gene functions, candidate metastasis-related events were validated in the MSK cohort with Fisher’s exact test. The molecular signature and tumor mutational burden were similar in paired samples, and the average mutational concordance was 42.0% ± 28.9%. Its metastatic mechanism is potentially a linear progression based on the metastatic seeding theory. Furthermore, mutated ataxia telangiectasia mutated and Rad3-related (ATR) and tet methylcytosine dioxygenase 2 (TET2) genes were significantly enriched in lymphatic metastases (p ≤ 0.05). Alterations in these two genes could be considered metastasis-related driving events. Mutated ATR and TET2 might play an active role in the metastasis of lymph nodes with NSCLC. More case enrollment and long-term follow-up will further verify the clinical significance of these two genes.Keywords
This publication has 37 references indexed in Scilit:
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsCancer Discovery, 2015
- Signatures of mutational processes in human cancerNature, 2013
- TETonic shift: biological roles of TET proteins in DNA demethylation and transcriptionNature Reviews Molecular Cell Biology, 2013
- Lymph node micrometastases detected by carcinoembryonic antigen mRNA affect long-term survival and disease-free interval in early-stage lung cancer patientsOncology Letters, 2012
- The DNA-damage response in human biology and diseaseNature, 2009
- ATR Mutation in Endometrioid Endometrial Cancer Is Associated With Poor Clinical OutcomesJournal of Clinical Oncology, 2009
- Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2009
- A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non–Small Cell Lung Cancer PatientsClinical Cancer Research, 2006
- Patient Subsets Benefiting from Adjuvant Therapy Following Surgical Resection of Non–Small Cell Lung CancerClinical Cancer Research, 2005
- cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.Proceedings of the National Academy of Sciences, 1996